Hermetica Superfood Encyclopedia
The Short Answer
Inocarpus fagifer seeds contain flavonoids (0.03% quercetin equivalent), linoleic acid, ethyl linoleic, ethyl oleic, and homopterocarpine, which collectively suppress oxidative stress by inducing superoxide dismutase (SOD) isoforms and reducing plasma malondialdehyde (MDA). In Wistar rat models of hypercholesterolemia, ethanol seed extract at 50–150 mg/kg body weight over 16 weeks significantly increased SOD-3 expression in aortic endothelial cells and decreased plasma MDA (p<0.05), suggesting anti-atherosclerotic potential pending human validation.
CategoryOther
GroupPacific Islands
Evidence LevelPreliminary
Primary KeywordInocarpus fagifer benefits
Ifi — botanical close-up
Health Benefits
**Antioxidant Activity**
Ethanol seed extract demonstrates DPPH radical inhibition with an IC50 of 280 ppm, attributable to flavonoids, linoleic acid derivatives, and homopterocarpine that quench free radicals and upregulate endogenous antioxidant enzymes.
**Anti-Atherosclerotic Effects**
Preclinical studies in hypercholesterolemic rats show that seed extract at 50 mg/kg upregulates SOD-3 expression in aortic endothelial cells and reduces circulating MDA, biomarkers associated with reduced oxidative damage to vascular tissue.
**Anti-inflammatory Potential**
The extract modulates pro-inflammatory cytokines including IL-6 and TNF-α, as well as the adhesion molecule ICAM-1 in aortic endothelial cells, pathways central to the initiation and progression of atherosclerotic plaques.
**Antidiarrheal Use (Traditional)**
Polynesian and Pacific Island traditions employ bark decoctions for the management of diarrhea, likely through astringent tannin constituents that reduce intestinal secretion and motility, though this application has not been formally investigated in controlled studies.
**Lipid Profile Modulation**
Animal model data indicate that seed extract influences lipid biomarkers in the context of high-cholesterol diets, with effects on SOD activity and MDA suggesting indirect protection of lipid integrity, though direct LDL/HDL measurements are not yet fully characterized in published literature.
**Nutritional Energy Source**
The starchy seeds are a traditional staple food across the Pacific, providing significant carbohydrate energy and modest protein, historically roasted or boiled and consumed as a famine reserve food due to the tree's prolific fruiting.
Origin & History
Natural habitat
Inocarpus fagifer is a tropical tree native to the Indo-Pacific region, distributed across Polynesia, Melanesia, Micronesia, and maritime Southeast Asia, where it thrives in coastal lowland forests, riverine margins, and humid valley floors at low elevations. The tree is cultivated and semi-wild throughout Pacific Island nations, including Samoa, Tonga, Fiji, and the Solomon Islands, as well as in parts of Indonesia and Malaysia. Known as 'ifi' in Samoan and Tongan, 'gatep' in parts of Indonesia, and 'gayam' in Bali, it has been a cornerstone food and medicine tree across Pacific cultures for centuries.
“Inocarpus fagifer has been cultivated and utilized across the Pacific Islands for at least several centuries, serving dual roles as a critical famine food and a medicinal plant in Polynesian, Melanesian, and Micronesian traditions, where the large starchy seeds were roasted and eaten as a staple when other crops failed. In Samoan and Tongan ethnomedicine, the bark is specifically employed as a remedy for diarrhea, prepared as a decoction, reflecting a pan-Pacific pattern of using astringent bark preparations for gastrointestinal complaints. In Bali and parts of Indonesia, the tree (called gayam) is considered culturally significant and is often planted near temples and homesteads, with seeds consumed as a seasonal food rather than primarily as medicine. The tree appears in early European botanical accounts of the Pacific, and was formally described by G. Forster during Cook's voyages, underscoring its longstanding visibility as an ethnobotanically important species.”Traditional Medicine
Scientific Research
The published scientific literature on Inocarpus fagifer is sparse and confined entirely to preclinical in vitro and animal studies, with no published human clinical trials as of the available evidence base. The most substantive work involves Wistar rat models of hypercholesterolemia receiving ethanol seed extract at 50–150 mg/kg/day for 16 weeks, demonstrating statistically significant increases in SOD-3 expression and decreases in plasma MDA (p<0.05), but these studies involve small animal cohorts and lack independent replication across multiple research groups. Antioxidant capacity has been quantified in vitro at DPPH IC50 of 280 ppm with flavonoid content of 0.03% quercetin equivalent, providing basic phytochemical characterization but no pharmacokinetic or bioavailability data. The traditional use of bark for diarrhea has not been subjected to any controlled preclinical or clinical investigation, leaving this application supported solely by ethnobotanical records.
Preparation & Dosage
Traditional preparation
**Traditional Bark Decoction (Antidiarrheal)**
Bark is boiled in water and the decoction consumed orally; specific volumes and concentrations used in Polynesian practice are not standardized in the ethnobotanical literature.
**Roasted/Boiled Seeds (Food Use)**
Seeds are traditionally roasted over open flame or boiled and eaten as a starchy staple; no supplemental dose equivalent applies to food use.
**Ethanol Seed Extract (Preclinical Research Form)**
50–150 mg/kg body weight in rats; allometric scaling suggests approximately 3
The only scientifically studied form is an ethanol extract of seeds, used at .5–5 g/day for a 70 kg human, but this dose has no human clinical validation.
**Standardization**
No commercial standardization exists for flavonoid content, homopterocarpine, or other bioactive markers; the research-grade extract contained 0.03% flavonoids (quercetin equivalent).
**Timing**
No timing data are available; animal studies administered extract daily over 16-week periods.
**Available Commercial Forms**
No standardized commercial supplement forms (capsules, powders, tinctures) are currently established in international markets; the ingredient is primarily accessed as a traditional food or local herbal preparation.
Nutritional Profile
The seeds of Inocarpus fagifer are primarily composed of starch and represent a significant carbohydrate energy source, historically providing subsistence calories across Pacific Island communities. The seeds contain moderate protein levels and small quantities of dietary fat, including linoleic acid (an omega-6 essential fatty acid) and oleic acid (an omega-9 monounsaturated fatty acid), as identified by GC-MS analysis of ethanol extracts. Phytochemical constituents include flavonoids at approximately 0.03% (quercetin equivalent), homopterocarpine (a pterocarpan isoflavonoid), ethyl linoleate, and ethyl oleate. The bark contains condensed tannins responsible for its astringent properties, though precise tannin concentrations have not been published. Bioavailability data for any specific phytochemical constituent in humans are entirely absent from the current literature.
How It Works
Mechanism of Action
The primary documented molecular mechanism of Inocarpus fagifer seed extract involves induction of superoxide dismutase isoforms, particularly SOD-2 (mitochondrial) and SOD-3 (extracellular), in aortic endothelial cells, thereby dismutating superoxide radicals (O₂⁻) into less reactive hydrogen peroxide and reducing oxidative vascular injury. Homopterocarpine, a pterocarpan-class isoflavonoid, and linoleic acid-derived compounds are believed to activate Nrf2-mediated antioxidant response elements, though direct Nrf2 pathway confirmation in this species has not been published. Simultaneously, the extract suppresses pro-inflammatory signaling by downregulating TNF-α, IL-6, and ICAM-1 expression in endothelial cells, reducing leukocyte adhesion and endothelial activation that precede atherosclerotic plaque formation. The bark's traditional antidiarrheal activity is hypothetically attributed to condensed tannins that precipitate intestinal mucosal proteins, reduce fluid secretion via prostaglandin inhibition, and exert mild antimicrobial effects, though these mechanisms remain uninvestigated at the molecular level.
Clinical Evidence
No human clinical trials have been conducted on Inocarpus fagifer in any form or for any indication. All mechanistic and efficacy data derive from preclinical animal experiments, primarily hypercholesterolemic rat models, and in vitro antioxidant assays. The most quantified outcome is the SOD-3 upregulation and MDA reduction observed at 50 mg/kg in rats over 16 weeks (p<0.05), which translates to an estimated human equivalent dose of approximately 3.5–5 g of seed extract for a 70 kg individual via allometric scaling, though this extrapolation is unvalidated. Confidence in therapeutic efficacy for any human health outcome remains very low, and no safety, tolerability, or pharmacokinetic data in humans exist; the ingredient's use in supplements or therapeutics would require prospective clinical investigation before evidence-based recommendations can be issued.
Safety & Interactions
No formal toxicological studies, adverse event reporting, or human safety assessments have been published for Inocarpus fagifer in any preparation form, making it impossible to define a maximum safe dose, identify dose-dependent side effects, or characterize a safety margin for supplemental use. The seeds are consumed as a traditional food across the Pacific without widely reported acute toxicity, suggesting reasonable tolerability at food-level intakes, but long-term supplemental use at extract concentrations has not been evaluated. No drug interaction data exist; however, given that the extract modulates SOD activity, inflammatory cytokines (TNF-α, IL-6), and vascular adhesion molecules, theoretical interactions with anticoagulants, immunosuppressants, and anti-inflammatory medications cannot be excluded. Pregnant and lactating women should avoid supplemental forms given the complete absence of reproductive safety data, though traditional consumption as a cooked food is a distinct context from concentrated extract use.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Inocarpus fagiferGayamGatepIfiPolynesian chestnutTahitian chestnutInocarpus edulis
Frequently Asked Questions
What is Inocarpus fagifer used for traditionally?
In Polynesian and broader Pacific Island traditional medicine, the bark of Inocarpus fagifer is decocted in water and consumed orally to treat diarrhea, an application attributed to the astringent properties of bark tannins. The seeds have been used as a staple food across Samoa, Tonga, Fiji, and other Pacific nations, particularly during food scarcity, and are roasted or boiled before eating.
Does Inocarpus fagifer have any proven health benefits?
Current evidence is limited to preclinical animal studies showing that ethanol seed extract at 50–150 mg/kg in hypercholesterolemic Wistar rats significantly increased SOD-3 expression in aortic endothelial cells and reduced plasma malondialdehyde (MDA) (p<0.05) over 16 weeks. No human clinical trials have been conducted, so no health benefits have been clinically proven in people.
What are the active compounds in Inocarpus fagifer seeds?
GC-MS and phytochemical analysis of Inocarpus fagifer seed ethanol extracts has identified homopterocarpine (a pterocarpan isoflavonoid), linoleic acid, ethyl linoleate, ethyl oleate, and flavonoids at approximately 0.03% quercetin equivalent as the primary bioactive constituents. These compounds are believed responsible for observed antioxidant (DPPH IC50 of 280 ppm) and anti-atherosclerotic activities in preclinical models.
Is Inocarpus fagifer safe to consume?
The cooked seeds have a long history of safe food use across Pacific Island communities, suggesting tolerability at dietary intake levels. However, no formal toxicological studies, maximum tolerated dose data, or human safety assessments have been published for supplemental extracts, and no drug interaction data exist; supplemental use should be approached with caution and medical guidance until safety data are available.
What is the recommended dose of Inocarpus fagifer extract?
No human clinical dose has been established. The only published dosing data come from animal studies using 50–150 mg/kg body weight of ethanol seed extract in rats, which allometrically scales to approximately 3.5–5 grams per day for a 70 kg adult human, but this extrapolation has not been validated in any human trial. No standardized commercial supplement form or evidence-based dosing protocol currently exists.
How does Inocarpus fagifer compare to other traditional Pacific antioxidant foods?
Inocarpus fagifer (ifi) demonstrates antioxidant activity with an IC50 of 280 ppm in DPPH radical inhibition assays, making it competitive with other traditional Polynesian foods rich in flavonoids and phenolic compounds. Unlike some common antioxidant sources, ifi's unique compounds include homopterocarpine and linoleic acid derivatives that work synergistically to upregulate endogenous antioxidant enzymes like SOD-3. The seed's potency is particularly notable given its historical use as a staple carbohydrate source rather than a specialized medicinal ingredient.
What is the difference between raw ifi seeds and standardized extracts for bioavailability?
Raw ifi seeds contain the full spectrum of bioactive compounds but have lower bioavailability due to the seed's tough outer coating and antinutrient content that may inhibit absorption. Ethanol extracts concentrate the active flavonoids, linoleic acid derivatives, and homopterocarpine, significantly improving their absorption and DPPH radical-quenching activity. Preclinical research used 50 mg/kg seed extract doses in animal models, suggesting that standardized extracts achieve therapeutic effects at lower overall consumption volumes than whole seeds.
What does current research show about ifi's cardiovascular benefits beyond cholesterol?
Preclinical studies in hypercholesterolemic rats demonstrate that ifi seed extract upregulates SOD-3 (superoxide dismutase-3), a key enzyme protecting blood vessel endothelium from oxidative stress—a primary mechanism in atherosclerosis development. Beyond lipid management, this SOD-3 upregulation suggests protective effects on arterial function and inflammation markers, though human clinical trials are needed to confirm these findings. The anti-atherosclerotic mechanism operates through both reducing oxidative damage and enhancing the body's natural antioxidant enzyme systems.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w ifi-inocarpus-fagifer curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
